Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer

Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer

Immune checkpoint inhibitor-related pneumonitis (ICI-P) during cancer treatment is rarely observed (<5%). ICI-P is more often observed in patients with nonsmall cell lung cancer (NSCLC) than in those with other cancers. Likewise, it is more common in those receiving programmed cell death (PD)-1/P...

Full description

Bibliographic Details
Main Authors: Jacques Cadranel, Anthony Canellas, Lise Matton, Marie Darrason, Antoine Parrot, Jean-Marc Naccache, Armelle Lavolé, Anne-Marie Ruppert, Vincent Fallet
Format: Article
Language:English
Published: European Respiratory Society 2019-10-01
Series:European Respiratory Review
Online Access:http://err.ersjournals.com/content/28/153/190058.full

Internet

http://err.ersjournals.com/content/28/153/190058.full

Similar Items